Cargando…
Systematically Prioritizing Candidates in Genome-Based Drug Repurposing
Drug repurposing is the application of approved drugs to treat diseases separate and distinct from their original indications. Herein, we define the scope of all practical precision drug repurposing using DrugBank, a publicly available database of pharmacological agents, and BioVU, a large, de-ident...
Autores principales: | Challa, Anup P., Lavieri, Robert R., Lewis, Judith T., Zaleski, Nicole M., Shirey-Rice, Jana K., Harris, Paul A., Aronoff, David M., Pulley, Jill M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921094/ https://www.ncbi.nlm.nih.gov/pubmed/31769998 http://dx.doi.org/10.1089/adt.2019.950 |
Ejemplares similares
-
Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases
por: Challa, Anup P., et al.
Publicado: (2021) -
Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer’s Disease in Real-World Clinical Datasets
por: Wei, Wei-Qi, et al.
Publicado: (2023) -
Systematic integration of biomedical knowledge prioritizes drugs for repurposing
por: Himmelstein, Daniel Scott, et al.
Publicado: (2017) -
The Astounding Breadth of Health Disparity: Phenome-Wide Effects of Race on Disease Risk
por: Pulley, Jill M., et al.
Publicado: (2020) -
Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing
por: Garana, Belinda B., et al.
Publicado: (2023)